Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Conditions
DLBCL - Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements · DLBCL, Nos Genetic Subtypes · High Grade B-Cell Lymphoma, Not Otherwise Specified · Follicular Large Cell Lymphoma, Relapsed · Follicular Large Cell Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Australasian Leukemia and Lymphoma Group, Melbourne, Victoria, Australia
Adrian Minson, MD (Sub-investigator)